The Medical Grand Rounds on Review of the expanding roles of SGLT2 inhibitors was held on October 14, 2021.

The Speaker was Dr. Shervin Zandi, Assistant Clinical Professor, Department of Medicine.

Objectives were: 

Review the evidence of SGLT2 inhibitors in: Diabetes, Heart Failure, Chronic Kidney Disease & Special considerations/precautions of SGLT2 inhibitors. 

Please see the  presentation on YouTube Channel of the Department of Medicine.
Accessibility for Ontarians With Disabilities Act (AODA)


The Faculty of Health Sciences is committed to providing a website that is accessible to the widest possible audience. If there is an accessibility issue with this website, please contact us at